Rilzabrutinib Impurity 13 | CAS 13206-46-7 - Request Quote
Rilzabrutinib Impurity 13
| SZ CAT No: | SZ-R099023 |
| CAS No | 13206-46-7 |
| Mol.F. | C4H7BrO |
| Mol.Wt. | 151.0 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rilzabrutinib Impurity 13 is chemically 2-Bromo-2-methylpropanal. Rilzabrutinib Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Rilzabrutinib Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rilzabrutinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 13206-46-7
Purchase 13206-46-7
Order 13206-46-7
Enquire 13206-46-7
price of 13206-46-7
13206-46-7 Supplier
13206-46-7 Manufacturer
13206-46-7 Exporter
buy high quality Rilzabrutinib Impurity 13
Purchase Rilzabrutinib Impurity 13
Rilzabrutinib Impurity 13 suppliers
Rilzabrutinib Impurity 13 manufacturers
Rilzabrutinib Impurity 13 price
Order Rilzabrutinib Impurity 13
Enquire Rilzabrutinib Impurity 13
Rilzabrutinib Impurity 13 cost
Rilzabrutinib Impurity 13 Supplier
Rilzabrutinib Impurity 13 Distributor
Rilzabrutinib Impurity 13 for Method Validation
Rilzabrutinib Reference Standard
Rilzabrutinib Impurity 13 for ANDA Filing
Rilzabrutinib Impurity 13 for Forced Degradation Studies
Rilzabrutinib Impurity 13 Identification Standards
Rilzabrutinib Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


